Somanetics Corporation (NASDAQ: SMTS) focuses on developing, manufacturing and marketing the INVOS® Cerebral/Somatic Oximeter. This non-invasive patient monitoring system constantly measures changes in the blood oxygen levels in patients with or at risk for restricted blood flow. The INVOS System also provides the information necessary to identify oxygen imbalances in tissues beneath the sensor, allowing medical professionals to take corrective action. For further information, visit the Company’s web site at www.somanetics.com.
- 16 years ago
QualityStocks
Somanetics Corporation (NASDAQ: SMTS)
Tags Rodman & Renshaw
Related Post
-
Zacks Initiates Coverage on SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2)
Despite policy uncertainty, demand for scalable solar and storage solutions in North America remains strong,…
-
Newton Golf Company (NASDAQ: NWTG) Rides Wave of Golf’s Rising Popularity with Innovation and Vision
The sport offers a unique blend of physical activity, mental challenge and social interaction. Newton…
-
ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Details Recent Achievements, Upcoming Milestones as It Advances Expanded Exploration at Montauban
ESGold has closed a C$3.4 million financing round, enabling final construction at its Montauban project…